Contact
Please use this form to send email to PR contact of this press release:
GlaxoSmithKline receives new approval for Rotarix and significant new indication for Lamictal® (lamotrigine) in Japan
TO:
Please use this form to send email to PR contact of this press release:
GlaxoSmithKline receives new approval for Rotarix and significant new indication for Lamictal® (lamotrigine) in Japan
TO: